Global Cosmetovigilance Market size and share is currently valued at USD 9.84 billion in 2023 and is anticipated to generate an estimated revenue of USD 15.38 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.1% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Market Overview
The cosmetics industry has witnessed tremendous growth in recent years, driven by product innovation, consumer awareness, and rising demand for clean, organic, and multifunctional products. With the proliferation of new ingredients and formulations, ensuring cosmetic product safety has become paramount.
In this environment, cosmetovigilance has emerged as a key discipline that ensures product quality and safety throughout the lifecycle—from development and clinical testing to post-market usage. Its purpose is to detect, assess, understand, and prevent adverse cosmetic events, including allergic reactions, irritations, dermatitis, and long-term effects.
Governments and international bodies such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have implemented stricter regulations that require companies to maintain detailed records of adverse effects and ensure regulatory compliance monitoring. In Europe, Regulation (EC) No 1223/2009 has made it mandatory for Responsible Persons to ensure cosmetovigilance systems are in place.
Market Segmentation
The cosmetovigilance market can be segmented by service type, mode of delivery, end user, and region.
By Service Type:
-
Pre-marketing Product Safety Assessment
-
Post-marketing Surveillance
-
Case Management
-
Signal Detection
-
Risk Management & Communication
Among these, post-marketing surveillance is projected to hold the largest market share through 2032. As cosmetic products are typically not subject to pre-market approval in many regions, real-world usage data and consumer feedback have become critical to identifying potential safety issues. Case management and signal detection services are also growing rapidly as companies aim to stay ahead of potential reputational and regulatory risks.
By Mode of Delivery:
-
In-house Cosmetovigilance
-
Outsourced Cosmetovigilance
The outsourced segment dominates the market, as many cosmetic companies—particularly SMEs and startups—lack the infrastructure or expertise to manage cosmetovigilance internally. Outsourcing provides access to specialized regulatory and pharmacovigilance professionals, robust reporting platforms, and real-time monitoring tools.
However, in-house cosmetovigilance is increasingly being adopted by large multinational companies with dedicated regulatory and legal departments. These companies are developing internal capabilities to enhance brand trust and ensure long-term compliance.
By End User:
-
Cosmetic Manufacturers
-
Contract Research Organizations (CROs)
-
Regulatory Consulting Firms
-
Healthcare Professionals & Dermatologists
-
Regulatory Authorities
Cosmetic manufacturers constitute the largest end-user segment, given their primary responsibility for product safety and compliance. CROs and regulatory consulting firms are gaining prominence by offering cost-effective and flexible cosmetovigilance solutions. Dermatologists and healthcare providers are essential stakeholders in identifying and reporting adverse cosmetic events to the appropriate regulatory agencies.
Regional Analysis
North America
North America is expected to retain a significant share of the global cosmetovigilance market, driven by a well-regulated cosmetic industry, increasing consumer expectations, and the presence of leading global cosmetics brands. The U.S. FDA oversees cosmetic regulations under the Federal Food, Drug, and Cosmetic Act (FD&C Act), which mandates post-market reporting and adverse event tracking.
Recent legislation such as the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) has further tightened requirements around cosmetic product safety, labeling, recordkeeping, and adverse event reporting, making regulatory compliance monitoring more stringent.
Europe
Europe is the most mature and regulated market for cosmetovigilance services, particularly due to the enforcement of EU Regulation 1223/2009, which mandates adverse effect reporting for all marketed cosmetic products. The Responsible Person (RP) must ensure a comprehensive post-marketing surveillance system is in place.
Germany, France, and the United Kingdom lead in the adoption of structured cosmetovigilance systems. Companies operating in Europe often partner with local pharmacovigilance firms or invest in in-house safety teams to maintain compliance.
Asia-Pacific
The Asia-Pacific region is projected to witness the fastest growth over the forecast period, fueled by rapid urbanization, rising cosmetic consumption, and a growing middle-class population. Countries like China, South Korea, Japan, and India are seeing a surge in demand for skincare and beauty products—especially among younger consumers.
Regulatory authorities like China’s National Medical Products Administration (NMPA) and India’s Central Drugs Standard Control Organization (CDSCO) are implementing more robust guidelines for post-market surveillance and product recalls, pushing manufacturers to adopt cosmetovigilance frameworks.
Latin America and Middle East & Africa
These regions are slowly catching up in terms of regulatory enforcement and consumer safety initiatives. Brazil, South Africa, and the UAE are investing in modernizing their regulatory frameworks, presenting new opportunities for service providers and manufacturers. Multinational cosmetic brands expanding into these regions are proactively implementing regulatory compliance monitoring strategies to avoid recalls and reputational damage.
Key Companies in the Cosmetovigilance Market
Several companies are actively engaged in providing end-to-end cosmetovigilance solutions, ranging from adverse event reporting to risk communication and regulatory support.
1. IQVIA Inc.
IQVIA offers specialized cosmetovigilance services through its pharmacovigilance unit, focusing on case processing, safety database management, and regulatory report submissions.
2. PharmaLex (Part of AmerisourceBergen)
PharmaLex supports cosmetic manufacturers with comprehensive regulatory and safety solutions, including pre- and post-marketing surveillance and global compliance consulting.
3. Cliantha Research
Cliantha provides dermatological safety studies and adverse cosmetic event reporting support, particularly for clinical trial sponsors and OTC product companies.
4. AB Cube
Known for its cloud-based pharmacovigilance platform, AB Cube also caters to the cosmetic industry, allowing real-time data entry and safety reporting.
5. AXPHARMA
AXPHARMA provides tailored regulatory compliance monitoring and cosmetovigilance services for European clients, including case assessment, signal detection, and reporting to the EU CPNP (Cosmetic Products Notification Portal).
6. Foresight Group International
Foresight delivers strategic pharmacovigilance and cosmetovigilance consulting services, including risk mitigation strategies and global regulatory submission support.
7. Techsol Corporation
Techsol has developed safety monitoring platforms that automate post-marketing surveillance processes, allowing cosmetic brands to detect and manage adverse trends efficiently.
Market Drivers
-
Stricter Global Regulations: Increased enforcement of product safety regulations across North America, Europe, and Asia-Pacific is a major driver.
-
Rise in Adverse Cosmetic Events: Growing consumer awareness and social media have made reporting of negative effects more common, necessitating robust cosmetovigilance systems.
-
Increased R&D and Innovation: The use of new active ingredients and formulations increases the need for cosmetic product safety evaluations.
-
Brand Protection and Consumer Trust: Transparent safety monitoring enhances brand reputation and consumer confidence.
Market Challenges
-
Lack of Harmonization Across Jurisdictions: Varied regulatory frameworks complicate global product launches and increase compliance costs.
-
Limited Reporting Infrastructure in Emerging Markets: Inadequate systems in developing regions hinder effective data collection and surveillance.
-
Underreporting of Mild Events: Many consumers fail to report non-serious adverse effects, making comprehensive surveillance difficult.
-
High Costs of In-house Systems: Building internal cosmetovigilance capabilities remains cost-prohibitive for smaller companies.
Explore More:
https://www.polarismarketresearch.com/industry-analysis/cosmetovigilance-market
Future Outlook
The future of the cosmetovigilance market is expected to be shaped by digital transformation, AI-powered adverse event prediction tools, mobile-based reporting apps, and blockchain for traceability. Companies are also expected to integrate cosmetovigilance with their broader ESG and sustainability strategies to ensure ethical and consumer-friendly product development.
As cosmetic science evolves and consumer advocacy gains strength, the emphasis on proactive safety management will only intensify—positioning cosmetovigilance as an indispensable component of modern cosmetic industry practices.
More Trending Latest Reports By Polaris Market Research:
Inflammatory Bowel Disease Treatment Market
Peripheral Vascular Device Market
Hematologic Malignancies Therapeutics Market
Parkinson’s Disease Treatment Market
Clinical Trial Technology and Services Market
Private Nursing Services Market
Specialty Generic Drugs Market
US Spatial Genomics and Transcriptomics Market
Spatial Genomics & Transcriptomics Market
US Organoid and Spheroid Market
Nonmydriatic Fundus Cameras Market
Veterinary Surgical Procedures Market
